

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lung neoplasms | D008175 | — | C34.90 | — | 1 | — | — | — | 1 |
| Small cell lung carcinoma | D055752 | — | — | — | 1 | — | — | — | 1 |
| Drug common name | AMUVATINIB |
| INN | amuvatinib |
| Description | N-(1,3-benzodioxol-5-ylmethyl)-4-(4-benzofuro[3,2-d]pyrimidinyl)-1-piperazinecarbothioamide is a N-arylpiperazine. |
| Classification | Small molecule |
| Drug class | tyrosine kinase inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1 |
| PDB | — |
| CAS-ID | 850879-09-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2103851 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | SO9S6QZB4R (ChemIDplus, GSRS) |
